Low demand for Covid-19 jabs
About 100 million doses a year are slated to be packaged and filled at a plant controlled by the BioVac Institute.
Plans to produce Pfizer Covid-19 vaccine in Cape Town may be scaled back because of waning demand for the shots, according to the head of the company’s South African manufacturin ...
If you are an active subscriber and the article is not showing, please log out and back in. Free access to articles from 12:00, only available to users who are logged in